Brigitte Smith

Brigitte Smith

Signal active

Co-Founder & Managing Partner

Bio

Brigitte Smith is the Co-Founder and Managing Partner at GBS since 1996. Brigitte has twenty years’ experience in venture capital, business strategy and start-up company operations. Brigitte has been investing and managing investments for GBS’s $450m of life science specialised venture capital funds since 1998.

Brigitte is on the board of GBS portfolio companies AirXpanders Inc, Endoluminal Sciences Pty Ltd, Neuromonics Pty Ltd, Proacta Inc, and Vivive Inc.

Brigitte was the founding Investor and Chair of Pharmaxis Pty Ltd.

Prior to founding GBS Brigitte worked in the US and Australia in operating roles with early stage technology based companies and at Bain & Company as a Strategic Management Consultant.

Brigitte has a B.Chem Eng (Honours) from the University of Melbourne and as a Fulbright Scholar completed a MBA (Honours) from the Harvard Business School and a MALD from the Fletcher School of Law and Diplomacy, both in Boston, USA.

Location

Melbourne, Victoria, Australia, Oceania

Social

Primary Organization

GBS Ventures

GBS Ventures

Founded

1996

Investment

63

Lead investment

18

Exits

13

Employees

1-10

Industry

Venture Capital

Jobs history

0

N/A

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Brigitte Smith is the Co-Founder & Managing Partner at GBS Ventures, based in Australia, Oceania. With a background in Venture Capital, Brigitte Smith has a rich history of leadership and innovation. Brigitte Smith studied Bachelor's Degree Chemical Engineering @ University of Melbourne. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

12

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
May 07, 2015
Moximed Moximed
Series B - Moximed
Moximed GBS Ventures
33.0M
Jan 27, 2016
Moximed Moximed
Series B - Moximed
Moximed GBS Ventures
12.6M
Mar 17, 2017
Moximed Moximed
Series C - Moximed
Moximed GBS Ventures
50.0M
Aug 16, 2022
Moximed Moximed
Series C - Moximed
Moximed GBS Ventures
40.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.